BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33038864
Number of visits today
372
Number of downloads
16231146
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Shah SB. COVID-19 and Progesterone: Part 2. Unraveling High Severity, Immunity Patterns, Immunity grading, Progesterone and its potential clinical use. Endocr Metab Sci 2021;:100110. [PMID: 34396354 DOI: 10.1016/j.endmts.2021.100110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Sharma A, Kaur M, Yadav P, Singh G, Barnwal RP. Expediting the drug discovery for ideal leads against SARS-CoV-2 via molecular docking of repurposed drugs. J Biomol Struct Dyn 2022;:1-17. [PMID: 36165445 DOI: 10.1080/07391102.2022.2127903] [Reference Citation Analysis]
2 Fedotcheva TA, Fedotcheva NI, Shimanovsky NL. Progesterone as an Anti-Inflammatory Drug and Immunomodulator: New Aspects in Hormonal Regulation of the Inflammation. Biomolecules 2022;12:1299. [DOI: 10.3390/biom12091299] [Reference Citation Analysis]
3 Yang D, Li H, Chen Y, Ren W, Dong M, Li C, Jiao Q. Immunomodulatory mechanisms of abatacept: A therapeutic strategy for COVID-19. Front Med 2022;9. [DOI: 10.3389/fmed.2022.951115] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hashimoto Y, Suzuki T, Hashimoto K. Mechanisms of action of fluvoxamine for COVID-19: a historical review. Mol Psychiatry 2022. [PMID: 34997196 DOI: 10.1038/s41380-021-01432-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 22.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345